Mainstream

ANI Pharmaceuticals raises 2025 guidance to $843M revenue and $7.35 EPS as Cortrophin Gel accelerates

ANI Pharmaceuticals raises 2025 guidance to $843M revenue and $7.35 EPS as Cortrophin Gel accelerates

Post ContentanipRead More

You might also be interested in reading XRP’s bull run might have ended at $3.65: Here’s what must happen to save it.

August 8, 2025
In Mainstream